This segment focuses on the research, development, and commercialization of pharmaceutical products, including MaxHeal skin restoration gel. Research and development activities include the formulation and testing of non-steroidal, anti-inflammatory compounds for skin restoration and relief from minor injuries and insect bites. The segment leverages chemical synthesis and formulation technologies. The primary therapeutic area is dermatology, with a focus on providing rapid relief and promoting skin healing. Patient impact is seen through the immediate soothing of skin irritations and the reduction of inflammation. Market positioning is based on providing effective, over-the-counter solutions. Future opportunities include expanding the product line and exploring new applications for existing compounds. Regulatory aspects involve compliance with FDA regulations for over-the-counter products. No current partnerships are mentioned in the search results.

This segment focuses on the development and commercialization of chemical solutions for the recovery of hydrocarbons from tar/oil sands, specifically SANDKLENE 950. Research and development activities involve the refinement and improvement of the chemical composition to enhance its efficiency and environmental profile. The segment utilizes chemical engineering and process optimization methodologies. The primary application is in the oil and gas industry, with a focus on improving the extraction of oil from challenging sources. Patient impact is indirect, contributing to the energy supply. Market positioning is based on providing a specialized solution for a niche market. Future opportunities include expanding the application of SANDKLENE 950 and developing new chemical solutions for the oil and gas industry. Regulatory aspects involve compliance with environmental regulations. The company has a license agreement related to SANDKLENE 950.